Breaking News Instant updates and real-time market news.

PFE

Pfizer

$35.59

-0.27 (-0.75%)

14:40
05/15/18
05/15
14:40
05/15/18
14:40

Pfizer biosimilar to Epogen and Procrit approved by FDA

Pfizer announced the United States Food and Drug Administration approved RETACRIT, a biosimilar to Epogen and Procrit, for all indications of the reference product. RETACRIT is now the first and only biosimilar erythropoiesis-stimulating agent to be approved in the U.S., the company noted. "RETACRIT is expected to be available in the U.S. at a significant discount to the current wholesaler acquisition cost of Epogen and Procrit. WAC is not inclusive of discounts to payers, providers, distributors and other purchasing organizations. Pfizer has entered into an agreement with Vifor Pharma Inc. for the commercialization of RETACRIT in certain channels. RETACRIT is Pfizer's third approved biosimilar in the U.S. Pfizer's biosimilars pipeline consists of 11 distinct biosimilar molecules with six assets in mid-to-late stage clinical development," the company said.

  • 20

    May

  • 05

    Jun

PFE Pfizer
$35.59

-0.27 (-0.75%)

05/15/18
LEER
05/15/18
NO CHANGE
Target $121
LEER
Outperform
Sarepta price target raised to $121 from $88 at Leerink
Leerink analyst Joseph Schwartz raised his price target for Sarepta (SRPT) to $121 from $88, while reiterating an Outperform rating on the shares. The analyst notes that Sarepta is one of three companies developing microdystrophin gene therapy for Duchenne muscular dystrophy, in competition with Pfizer (PFE) who acquired Bamboo, and Solid Biosciences (SLDB). With Solid's clinical hold still in place, Sarepta could potentially be first-to-market, and is expected to report the first clinical data for a micro-dystrophin candidate at their R&D day on June 19, he adds.
04/19/18
04/19/18
NO CHANGE

BTIG says Allergan may be interested in Shire after insufficient Takeda offers
BTIG analyst Timothy Chiang noted that Shire (SHPG) is trading higher after news that at least one other company other than Takeda (TKPYY) is interested in acquiring Shire, and naming Allergan (AGN) as one of those possible suitors. Chiang also believes that other companies, such as Pfizer (PFE), could entering into the bidding for Shire. BTIG maintained a Buy rating and $195 price target on Shire shares.
04/16/18
NORL
04/16/18
NO CHANGE
NORL
Outperform
Pfizer appears to be BioLife Solutions customer, says Northland
Northland analyst Suraj Kalia believes Pfizer (PFE) has never publicly announced itself as a customer of BioLife Solutions (BLFS), but a link to a presentation apparently made at the AAPS conference seems to highlight Pfizer' use of BioLife's CryoStor cryopreservation medium in its CAR-T program. Kalie noted this is the first time he has learned of Pfizer being a customer and of the use of BioLife's CryoStor being used in allogeneic CAR-T applications, both of which he finds interesting. Kalia has an Outperform rating on BioLife.
04/12/18
SBSH
04/12/18
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $78 at Citi
Citi analyst Andrew Baum lowered his price target for Bristol-Myers Squibb (BMY) to $70 after Pfizer (PFE) management made clear to him that they had no interest in acquiring Bristol without transformational data or a de-rating in the shares. The analyst removed the $8 per share risk adjusted M&A premium from his Bristol-Myers target price. He views his new price target as conservative, however, and keeps a Buy rating on the name.

TODAY'S FREE FLY STORIES

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

, WTW

Weight Watchers

$47.47

-0.32 (-0.67%)

09:12
11/14/18
11/14
09:12
11/14/18
09:12
Hot Stocks
Blue Apron says it will launch new partnership with Weight Watchers »

Blue Apron (APRN) says…

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

WTW

Weight Watchers

$47.47

-0.32 (-0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 28

    Nov

EAGL

Platinum Eagle Acquisition Corp.

$9.90

0.03 (0.30%)

09:11
11/14/18
11/14
09:11
11/14/18
09:11
Conference/Events
Platinum Eagle Acquisition Corp. to hold a conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAH

Booz Allen

$51.81

0.52 (1.01%)

09:10
11/14/18
11/14
09:10
11/14/18
09:10
Hot Stocks
Booz Allen awarded 10-year $2.5B IT contract by SEC »

To keep pace with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$35.77

-1.27 (-3.43%)

, GOOS

Canada Goose

$58.60

1.51 (2.64%)

09:09
11/14/18
11/14
09:09
11/14/18
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS: Macys…

M

Macy's

$35.77

-1.27 (-3.43%)

GOOS

Canada Goose

$58.60

1.51 (2.64%)

QIWI

Qiwi

$12.75

0.16 (1.27%)

TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

APRN

Blue Apron

$1.22

-0.03 (-2.40%)

WIX

Wix.com

$91.30

2.83 (3.20%)

TLRY

Tilray

$111.25

-1.95 (-1.72%)

AMAL

Amalgamated Bank

$22.75

1 (4.60%)

TEN

Tenneco

$33.61

-0.04 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 28

    Nov

  • 14

    Nov

SIVB

SVB Financial

$242.68

1.84 (0.76%)

09:09
11/14/18
11/14
09:09
11/14/18
09:09
Recommendations
SVB Financial analyst commentary  »

SVB acquisition of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

GWPH

GW Pharmaceuticals

$132.13

-2.35 (-1.75%)

09:08
11/14/18
11/14
09:08
11/14/18
09:08
Initiation
GW Pharmaceuticals initiated  »

Leerink likes new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

SWCH

Switch

$9.27

-0.075 (-0.80%)

, EBAY

eBay

$28.10

-0.86 (-2.97%)

09:07
11/14/18
11/14
09:07
11/14/18
09:07
Recommendations
Switch, eBay analyst commentary  »

Switch price target…

SWCH

Switch

$9.27

-0.075 (-0.80%)

EBAY

eBay

$28.10

-0.86 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

NYNY

Empire Resorts

$8.65

0.95 (12.34%)

09:05
11/14/18
11/14
09:05
11/14/18
09:05
Hot Stocks
Empire Resorts, bet365 affiliate form strategic alliance to offer sports betting »

Empire Resorts and an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$23.52

-0.17 (-0.72%)

09:05
11/14/18
11/14
09:05
11/14/18
09:05
Recommendations
Teva analyst commentary  »

Teva management sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

09:05
11/14/18
11/14
09:05
11/14/18
09:05
General news
U.S. equities are in rebound mode »

U.S. equities are in…

LUV

Southwest

$52.73

0.83 (1.60%)

09:04
11/14/18
11/14
09:04
11/14/18
09:04
Conference/Events
National Transportation Safety Board to hold an investigative hearing »

The National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$162.64

-1.185 (-0.72%)

09:03
11/14/18
11/14
09:03
11/14/18
09:03
Initiation
Allergan initiated  »

Leerink sees Allergan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ABT

Abbott

$69.50

-1.06 (-1.50%)

09:02
11/14/18
11/14
09:02
11/14/18
09:02
Hot Stocks
Abbott recommends rejection of below-market mini-tender offer by Baker Mills »

Abbott received notice of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

APD

Air Products

$158.15

0.65 (0.41%)

09:02
11/14/18
11/14
09:02
11/14/18
09:02
Hot Stocks
Air Products, Sonatrach announce industrial gases agreements in Algeria »

Air Products and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CTSH

Cognizant

$69.59

0.03 (0.04%)

09:00
11/14/18
11/14
09:00
11/14/18
09:00
Recommendations
Cognizant analyst commentary  »

Cognizant investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 26

    Nov

  • 02

    Dec

AMAT

Applied Materials

$33.48

0.87 (2.67%)

08:59
11/14/18
11/14
08:59
11/14/18
08:59
Recommendations
Applied Materials analyst commentary  »

Applied Materials price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VERI

Veritone

$6.75

-0.14 (-2.03%)

08:58
11/14/18
11/14
08:58
11/14/18
08:58
Recommendations
Veritone analyst commentary  »

Veritone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

SABR

Sabre

$25.17

0.27 (1.08%)

08:57
11/14/18
11/14
08:57
11/14/18
08:57
Conference/Events
Sabre to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

ECA

Encana

$8.10

-0.315 (-3.75%)

, AAPL

Apple

$192.23

-1.925 (-0.99%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Options
Notable open interest changes for November 14th »

Tuesday's total…

ECA

Encana

$8.10

-0.315 (-3.75%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

GE

General Electric

$8.61

0.625 (7.83%)

M

Macy's

$35.77

-1.27 (-3.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

PETQ

PetIQ

$31.27

-1.77 (-5.36%)

08:56
11/14/18
11/14
08:56
11/14/18
08:56
Recommendations
PetIQ analyst commentary  »

PetIQ price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BATRA

Liberty Braves Group

$25.06

0.15 (0.60%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

FWONA

Formula One Group

$31.01

0.47 (1.54%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Formula One Group to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

BATRK

Liberty Braves

$24.88

0.02 (0.08%)

08:55
11/14/18
11/14
08:55
11/14/18
08:55
Conference/Events
Liberty Braves to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

08:54
11/14/18
11/14
08:54
11/14/18
08:54
Conference/Events
Federal Reserve Bank of Dallas president participates in a discussion »

Federal Reserve Bank of…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

08:53
11/14/18
11/14
08:53
11/14/18
08:53
Recommendations
Qorvo, Lumentum, Apple analyst commentary  »

Qorvo price target…

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

LITE

Lumentum

$38.95

1.445 (3.85%)

AAPL

Apple

$192.23

-1.925 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.